Effectiveness of Acapella and ELTGOL Technique to Promote Airway Clearance in COPD:a Comparative Study

PSG College of Physiotherapy30 enrolled

Overview

To compare the efficacy of acapella and expiration against open glottis (ELTGOL) technique in promoting airway clearance of chronic obstructive pulmonary disease (COPD) patients

This study is carried out to determine the effectiveness of acapella and expiration in lateral position with open glottis to clear the secretion in COPD patients. The sessions will be carried twice daily for twenty minutes. The outcome measures are values of pre and post intervention fev1/fvc and breathlessness cough sputum scale. Duration of the study will be for five days.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

Conditions

Chronic Obstructive Pulmonary Disease

Interventions

AcapellaDEVICE

Treatment time for 20 min twice daily

ELTGOLOTHER

ELTGOL technique 20 min twice daily

conventional physiotherapyOTHER

Conventional physiotherapy was given twice daily for 20 min

Eligibility

Sex: ALLMin age: 30 YearsMax age: 80 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Mild copd * Moderate copd * Patient able to sustain expiratory flow greater than 15l/min * Patient expectorate more than 25.-30ml Exclusion Criteria: * Severe copd * Peripheral oxygen saturation lower than 85% * Rr\>35breaths/min * Current acute chest pain * Recent history of haemoptysis

Locations (1)

Steffi Varghese

Coimbatore, Tamil Nadu, India

RECRUITING

Outcomes

Primary Outcomes

Change in Force expiratory volume in one second

Fev1/fvc values were noted after pre and post intervention of airway clearance manoeuver

Time frame: change from baseline at 30 minutes

Secondary Outcomes

Change in breathlessness cough sputum score

Bcss scale was interviewed to the patient on first day and the fifth day. The changes were noted.

Time frame: change from baseline at 5 days

Central Contacts

steffi varghese, mpt

CONTACT

9677465724 steffivarghesep@gmail.com

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.